Sphingolipids are a class of bioactive lipids that play critical roles in cellular processes and are linked to various diseases. Recent studies have revealed the complexity of sphingolipid metabolism, highlighting their involvement in signaling pathways, cell growth, death, and disease. Key sphingolipids include ceramide, sphingosine, and S1P, which regulate downstream effectors and cellular functions. The metabolism of sphingolipids involves multiple enzymes and pathways, with over 40 enzymes in mammals involved in their processing. These enzymes are regulated by various mechanisms, including phosphorylation, deacetylation, and interactions with other proteins. The regulation of sphingolipid metabolism is essential for understanding their roles in health and disease. Sphingolipid metabolism is compartmentalized, with enzymes localized to specific cellular compartments, such as the plasma membrane, endoplasmic reticulum, and mitochondria. This compartmentalization is crucial for the proper functioning of sphingolipids and their metabolic pathways. The metabolism of sphingolipids is also influenced by other lipids and their interactions, contributing to the complexity of lipid signaling. The study of sphingolipid metabolism has led to the identification of new enzymes and pathways, as well as the development of therapeutic targets for sphingolipid-related diseases. Sphingolipids are involved in various physiological and pathophysiological processes, including immune responses, inflammation, cancer, and metabolic disorders. They regulate cell signaling, cell adhesion, and membrane dynamics, and their dysregulation is associated with diseases such as cancer, diabetes, and cardiovascular disorders. The study of sphingolipid metabolism has provided insights into the molecular mechanisms underlying these diseases and has led to the development of therapeutic strategies targeting sphingolipid pathways. The complexity of sphingolipid metabolism underscores the importance of understanding their roles in health and disease.Sphingolipids are a class of bioactive lipids that play critical roles in cellular processes and are linked to various diseases. Recent studies have revealed the complexity of sphingolipid metabolism, highlighting their involvement in signaling pathways, cell growth, death, and disease. Key sphingolipids include ceramide, sphingosine, and S1P, which regulate downstream effectors and cellular functions. The metabolism of sphingolipids involves multiple enzymes and pathways, with over 40 enzymes in mammals involved in their processing. These enzymes are regulated by various mechanisms, including phosphorylation, deacetylation, and interactions with other proteins. The regulation of sphingolipid metabolism is essential for understanding their roles in health and disease. Sphingolipid metabolism is compartmentalized, with enzymes localized to specific cellular compartments, such as the plasma membrane, endoplasmic reticulum, and mitochondria. This compartmentalization is crucial for the proper functioning of sphingolipids and their metabolic pathways. The metabolism of sphingolipids is also influenced by other lipids and their interactions, contributing to the complexity of lipid signaling. The study of sphingolipid metabolism has led to the identification of new enzymes and pathways, as well as the development of therapeutic targets for sphingolipid-related diseases. Sphingolipids are involved in various physiological and pathophysiological processes, including immune responses, inflammation, cancer, and metabolic disorders. They regulate cell signaling, cell adhesion, and membrane dynamics, and their dysregulation is associated with diseases such as cancer, diabetes, and cardiovascular disorders. The study of sphingolipid metabolism has provided insights into the molecular mechanisms underlying these diseases and has led to the development of therapeutic strategies targeting sphingolipid pathways. The complexity of sphingolipid metabolism underscores the importance of understanding their roles in health and disease.